Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 1.085 AUD 5.85% Market Closed
Updated: May 19, 2024

Mesoblast Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mesoblast Ltd
Gross Profit Peer Comparison

Comparables:
IMM
CSL
CUV
TLX
PYC

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Mesoblast Ltd
ASX:MSB
Gross Profit
-$14.3m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immutep Ltd
ASX:IMM
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Gross Profit
$7.3B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
10%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Gross Profit
AU$95.4m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Gross Profit
AU$314.4m
CAGR 3-Years
362%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mesoblast Ltd's Gross Profit?
Gross Profit
-14.3m USD

Based on the financial report for Dec 31, 2023, Mesoblast Ltd's Gross Profit amounts to -14.3m USD.

What is Mesoblast Ltd's Gross Profit growth rate?
Gross Profit CAGR 3Y
10%

Over the last year, the Gross Profit growth was 43%. The average annual Gross Profit growth rates for Mesoblast Ltd have been 10% over the past three years .